Search

everythinglearnresearchcommunity

for

Search:↓

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

The COVID-19 pandemic led to more young people getting red stretch marks due to lifestyle changes like less activity and quick weight gain.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

COVID-19 may harm male fertility and damage the reproductive system.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Anabolic steroid users may face higher risk of severe COVID-19.

Social media data can help track and predict COVID-19 symptoms and trends.

Insulin resistance linked to obesity may increase COVID-19 severity.

The treatment might help COVID-19 related hair loss, but more research is needed.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

Testosterone may influence COVID-19 severity and outcomes.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Testosterone's effects on COVID-19 are unclear and need more research.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Some drugs may help treat both COVID-19 and radiation injury.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.